
Leigh C. Maier
Examiner (ID: 12110, Phone: (571)272-0656 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1614, 1621, 1693 |
| Total Applications | 1395 |
| Issued Applications | 727 |
| Pending Applications | 80 |
| Abandoned Applications | 594 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17922813
[patent_doc_number] => 11466046
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => 14-membered ketolides and methods of their preparation and use
[patent_app_type] => utility
[patent_app_number] => 16/843259
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 1
[patent_no_of_words] => 66831
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 634
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16843259
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/843259 | 14-membered ketolides and methods of their preparation and use | Apr 7, 2020 | Issued |
Array
(
[id] => 16153733
[patent_doc_number] => 20200215099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 16/819770
[patent_app_country] => US
[patent_app_date] => 2020-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23482
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16819770
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/819770 | NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES | Mar 15, 2020 | Abandoned |
Array
(
[id] => 16341568
[patent_doc_number] => 20200306218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => Ophthalmic composition for treating dry eye and symptoms thereof
[patent_app_type] => utility
[patent_app_number] => 16/811618
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8880
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16811618
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/811618 | Ophthalmic composition for treating dry eye and symptoms thereof | Mar 5, 2020 | Abandoned |
Array
(
[id] => 16296238
[patent_doc_number] => 20200281961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => GLUCOCEREBROSIDE TREATMENT OF DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/801385
[patent_app_country] => US
[patent_app_date] => 2020-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16801385
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/801385 | GLUCOCEREBROSIDE TREATMENT OF DISEASE | Feb 25, 2020 | Abandoned |
Array
(
[id] => 16619973
[patent_doc_number] => 20210038626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => COMPOSITIONS COMPRISING AND METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2
[patent_app_type] => utility
[patent_app_number] => 16/792803
[patent_app_country] => US
[patent_app_date] => 2020-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16792803
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/792803 | COMPOSITIONS COMPRISING AND METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2 | Feb 16, 2020 | Abandoned |
Array
(
[id] => 16204816
[patent_doc_number] => 20200237806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => METHOD OF INHIBITING INFLAMMATORY RESPONSE USING LIPOPOLYSACCHARIDE OF PARABACTEROIDES GOLDSTEINII
[patent_app_type] => utility
[patent_app_number] => 16/747904
[patent_app_country] => US
[patent_app_date] => 2020-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7148
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16747904
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/747904 | Method of inhibiting inflammatory response using lipopolysaccharide of | Jan 20, 2020 | Issued |
Array
(
[id] => 17490485
[patent_doc_number] => 11279774
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-22
[patent_title] => Cyclodextrin dimers, compositions thereof, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/733945
[patent_app_country] => US
[patent_app_date] => 2020-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 179
[patent_figures_cnt] => 192
[patent_no_of_words] => 44691
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16733945
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/733945 | Cyclodextrin dimers, compositions thereof, and uses thereof | Jan 2, 2020 | Issued |
Array
(
[id] => 17815445
[patent_doc_number] => 11421044
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Nitric oxide-releasing antibacterial polymers and scaffolds fabricated therefrom and methods pertaining thereto
[patent_app_type] => utility
[patent_app_number] => 16/725566
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 21
[patent_no_of_words] => 26895
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16725566
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/725566 | Nitric oxide-releasing antibacterial polymers and scaffolds fabricated therefrom and methods pertaining thereto | Dec 22, 2019 | Issued |
Array
(
[id] => 17458726
[patent_doc_number] => 20220072030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => PHARMACEUTICAL FORMULATIONS AND COMPOSITIONS SUITABLE TO TREAT MUCOSITIS
[patent_app_type] => utility
[patent_app_number] => 17/299109
[patent_app_country] => US
[patent_app_date] => 2019-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299109
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/299109 | PHARMACEUTICAL FORMULATIONS AND COMPOSITIONS SUITABLE TO TREAT MUCOSITIS | Nov 25, 2019 | Abandoned |
Array
(
[id] => 17356850
[patent_doc_number] => 20220017646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => METHODS AND COMPOSITIONS FOR ACHIEVING HEMOSTASIS AND STABLE BLOOD CLOT FORMATION
[patent_app_type] => utility
[patent_app_number] => 17/295090
[patent_app_country] => US
[patent_app_date] => 2019-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -98
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295090
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/295090 | Methods and compositions for achieving hemostasis and stable blood clot formation | Nov 18, 2019 | Issued |
Array
(
[id] => 17355459
[patent_doc_number] => 20220016255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/276263
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19052
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17276263
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/276263 | Pharmaceutical composition containing a hyaluronic acid derivative | Nov 14, 2019 | Issued |
Array
(
[id] => 16877980
[patent_doc_number] => 11028113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => Cyphomycin, compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/664722
[patent_app_country] => US
[patent_app_date] => 2019-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 8914
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 397
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16664722
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/664722 | Cyphomycin, compositions and uses thereof | Oct 24, 2019 | Issued |
Array
(
[id] => 17192096
[patent_doc_number] => 11160826
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-11-02
[patent_title] => Cholesterol lowering drugs for the treatment of hepatic encephalopathy
[patent_app_type] => utility
[patent_app_number] => 16/663217
[patent_app_country] => US
[patent_app_date] => 2019-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 82
[patent_no_of_words] => 27610
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16663217
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/663217 | Cholesterol lowering drugs for the treatment of hepatic encephalopathy | Oct 23, 2019 | Issued |
Array
(
[id] => 15493117
[patent_doc_number] => 20200046747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => SIALYLATION-INCREASING THERAPIES FOR DISEASES ASSOCIATED WITH OXIDATIVE STRESS
[patent_app_type] => utility
[patent_app_number] => 16/655004
[patent_app_country] => US
[patent_app_date] => 2019-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16655004
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/655004 | SIALYLATION-INCREASING THERAPIES FOR DISEASES ASSOCIATED WITH OXIDATIVE STRESS | Oct 15, 2019 | Abandoned |
Array
(
[id] => 17183810
[patent_doc_number] => 20210330695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => TREATMENT OF PAIN WITH POLYSULFATED POLYSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 17/284071
[patent_app_country] => US
[patent_app_date] => 2019-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17284071
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/284071 | Treatment of pain with polysulfated polysaccharides | Oct 9, 2019 | Issued |
Array
(
[id] => 17414119
[patent_doc_number] => 20220049023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => NOVEL CRYSTALLINE FORMS OF SUGAMMADEX
[patent_app_type] => utility
[patent_app_number] => 17/276237
[patent_app_country] => US
[patent_app_date] => 2019-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17276237
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/276237 | NOVEL CRYSTALLINE FORMS OF SUGAMMADEX | Sep 24, 2019 | Abandoned |
Array
(
[id] => 19368370
[patent_doc_number] => 12060442
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-13
[patent_title] => Use of ethoxylated fatty amido alcohols as a reactivity additive in the process wherein cellulose is reacted with lye
[patent_app_type] => utility
[patent_app_number] => 17/278019
[patent_app_country] => US
[patent_app_date] => 2019-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4240
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17278019
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/278019 | Use of ethoxylated fatty amido alcohols as a reactivity additive in the process wherein cellulose is reacted with lye | Sep 22, 2019 | Issued |
Array
(
[id] => 16175467
[patent_doc_number] => 20200222435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => MIXTURE OF NON-DIGESTIBLE OLIGOSACCHARIDES FOR STIMULATING THE IMMUNE SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/577691
[patent_app_country] => US
[patent_app_date] => 2019-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4996
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16577691
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/577691 | Mixture of non-digestible oligosaccharides for stimulating the immune system | Sep 19, 2019 | Issued |
Array
(
[id] => 18085566
[patent_doc_number] => 11535684
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Chitosan derivatives and methods for preparing the same
[patent_app_type] => utility
[patent_app_number] => 17/270237
[patent_app_country] => US
[patent_app_date] => 2019-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10158
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 351
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17270237
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/270237 | Chitosan derivatives and methods for preparing the same | Aug 22, 2019 | Issued |
Array
(
[id] => 15321011
[patent_doc_number] => 20200000835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN
[patent_app_type] => utility
[patent_app_number] => 16/549405
[patent_app_country] => US
[patent_app_date] => 2019-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13845
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16549405
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/549405 | TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN | Aug 22, 2019 | Abandoned |